Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Advanced Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06991478
What this trial is testing

SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

Who this might be right for
Solid Tumor, Malignant Ascites
Tianjin Medical University Cancer Institute and Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT07480733
What this trial is testing

Phase II Study of JS212/JS213 as Monotherapy and in Combination in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Shanghai Junshi Bioscience Co., Ltd. 410
Early research (Phase 1)Temporarily pausedNCT05791448
What this trial is testing

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Who this might be right for
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more
University of Southern California 36
Early research (Phase 1)Looking for participantsNCT06021626
What this trial is testing

CRD3874-SI in People With Solid Tumors

Who this might be right for
SarcomaMerkel Cell Carcinoma
Memorial Sloan Kettering Cancer Center 81
Early research (Phase 1)UnknownNCT05190185
What this trial is testing

A Clinical Trial of TAA06 Injection in Advanced Solid Tumors

Who this might be right for
Malignant Melanoma, Lung Cancer, or Colorectal Cancer
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Early research (Phase 1)Study completedNCT01657214
What this trial is testing

Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients

Who this might be right for
Neoplasm Malignant
Sanofi 70
Early research (Phase 1)Not Yet RecruitingNCT07657585
What this trial is testing

CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 91
Early research (Phase 1)Not Yet RecruitingNCT07475559
What this trial is testing

JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors

Who this might be right for
Advanced Solid Tumor Malignancies
Jiangsu Alphamab Biopharmaceuticals Co., Ltd 42
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Early research (Phase 1)WithdrawnNCT04498520
What this trial is testing

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+32 more
Pamela Munster
Early research (Phase 1)Active Not RecruitingNCT01434316
What this trial is testing

Veliparib and Dinaciclib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Neoplasm
National Cancer Institute (NCI) 121
Testing effectiveness (Phase 2)Study completedNCT01017731
What this trial is testing

Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes

Who this might be right for
CancerSolid Tumor
Eli Lilly and Company 68
Early research (Phase 1)Looking for participantsNCT05245500
What this trial is testing

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Who this might be right for
MesotheliomaNon Small Cell Lung CancerMalignant Peripheral Nerve Sheath Tumors+3 more
Bristol-Myers Squibb 336
Very early researchLooking for participantsNCT07378436
What this trial is testing

A Clinical Study of GK02 in Malignant Ascites

Who this might be right for
Malignant Ascites Caused by Advanced Solid Tumors
Beijing Geekgene Technology Co., LTD 9
Early research (Phase 1)Study completedNCT00004241
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Looking for participantsNCT07583654
What this trial is testing

Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors

Who this might be right for
mRNA VaccineSolid Tumor CancerPeptides+1 more
West China Hospital 18
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Early research (Phase 1)Ended earlyNCT04042480
What this trial is testing

SGN-CD228A in Advanced Solid Tumors

Who this might be right for
Cutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more
Seagen Inc. 88
Early research (Phase 1)Active Not RecruitingNCT06150183
What this trial is testing

Safety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
BioNTech SE 41
Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Next Page